Fundraising Fox
VERO Biotech
226 employees on LinkedIn · 4 known investors
Find your way into VERO Biotech
Sign up to find every way you can get introduced to VERO Biotech
- Your email: who you already know at VERO Biotech, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the VERO Biotech team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
VERO Biotech develops next-generation inhaled nitric oxide (iNO) delivery systems for patients with cardiopulmonary conditions in acute care hospital settings. The company focuses on designing and commercializing innovative medical devices to address unmet clinical needs.
Investors · 4
Brace Pharmalisted by Brace PharmaAtlanta
How we know: Brace Pharma's portfolio page · Not right? Tell us
Runway Growth Capitallisted by Runway Growth CapitalMenlo Park · $10M – $150M
How we know: Runway Growth Capital's portfolio page · funding news · press coverage · Not right? Tell us
MVM Life Science PartnersreportedLondon · $20M – $100M
How we know: press coverage · Not right? Tell us
Also in the syndicate · 1
Petrichorlead
Related companies · 2
Vero BioscienceVero BioScience develops a blood-based proteomic test that measures organ-specific protein signatures to assess the biological age of individual organs and detect early signs of age-related disease. The company targets individuals seeking predictive health insights and preventive medicine interventions based on technology developed at Stanford.
PreqinPreqin provides a data and intelligence platform for investment teams, M&A professionals, and corporate development teams to source, evaluate, and value private company investments through integrated asset, fund, and performance data.
Companies working in the same space as VERO Biotech.
In the news
Frequently asked questions
- What does VERO Biotech do?
- VERO Biotech develops next-generation inhaled nitric oxide (iNO) delivery systems for patients with cardiopulmonary conditions in acute care hospital settings. The company focuses on designing and commercializing innovative medical devices to address unmet clinical needs.
- Who are VERO Biotech's investors?
- VERO Biotech's investors include Brace Pharma, Runway Growth Capital, MVM Life Science Partners.